Elenco degli articoli con argomento «idrosadenite suppurativa»
Dermatologia05 mar 2024
Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305
Hidradenitis suppurativa is a painful immune-mediated disorder with limited treatment options
24 nov 2023
Un aggiornamento per te da EADV 2023
Inibitori di JAK nelle indicazioni dermatologiche
25 ott 2023
Intervista Prof. Angelo Valerio Marzano
I Gruppi Italiano (Task Force della Sidemast) e i Gruppi Europei che si occupano di idrosadenite suppurativa si confrontano
25 ott 2023
Guselkumab for the treatment of patients
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that causes substantial physical
15 mag 2023
Quattro eventi SIDeMaST questo mese - maggio 2023
Tre webinar e una FAD con accreditamento ECM
04 mag 2023
Quality of life measurement in rosacea
The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient-Oriented Outcomes and Acne
31 mar 2023
Le armi SIDeMaST per contrare l'idrosadenite
In arrivo novità terapeutiche farmacologiche e chirurgiche. Costituita una task force multispecialistica che prenderà in carico il paziente a 360 gradi.
30 gen 2023
Hidradenitis Suppurativa Burdens on Mental Health
Skin, mental health and the central nervous system (CNS) are connected by a deep link. It is not only the aesthetic and sometimes
13 dic 2022
Current Medical and Surgical Treatment
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease presenting with recurrent inflammatory lesions in intertriginous body regions.
28 set 2022
Giro di boa coi nuovi farmaci Biologici di nuova generazione
Pelle sempre più "pulita" per i pazienti con psoriasi. Infiammazione "sedata" per quanti, colpiti da idrosadenite
25 lug 2022
Quali le più diffuse e come si curano malattie rare della pelle?
Idrosadenite suppurativa, psoriasi pustolosa, malattie bollose e vasculti sono patologie rare e poco conosciute ai più che condizionano la qualità della vita delle persone.
14 mar 2022
Hidradenitis Suppurativa: Where We Are and Where We Are Going
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease primarily affecting apocrine gland-rich areas of the body.
10 gen 2022
Hidradenitis suppurativa in pediatric patients
Hidradenitis suppurativa (HS) generally appears after puberty, is infrequently seen in younger children, and early onset, which is associated with more widespread disease, is more common in children with a positive family history of HS.
14 giu 2021
Factors related to the onset and recurrence of flares
Hidradenitis suppurativa (HS) is characterized by periodic worsening of symptoms.
04 mar 2021
Real-Time Confocal Imaging
Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease involving the follicular unit.
13 gen 2021
Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association
The co-existence of hidradenitis suppurativa (HS) and atopic dermatitis (AD) had been reported but was not investigated in controlled studies.
30 ago 2020
Efficacy and safety of topical resorcinol 15% as long‐term treatment of mild‐to‐moderate hidradenitis suppurativa
a valid alternative to clindamycin in the panorama of antibiotic resistance
09 giu 2020
Hidradenitis Suppurativa: An Update on Epidemiology, Phenotypes, Diagnosis, Pathogenesis, Comorbidities and Quality of Life
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that severely impairs patients' quality of life. It is characterized by recurrent painful nodules, abscesses and draining sinus tracts in primarily intertriginous areas.
26 apr 2020
Emerging medical treatments for hidradenitis suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory disease affecting intertriginous skin areas, and it is characterized by recurrent painful episodes of inflammatory drainage.
29 ott 2019
Hidradenitis Suppurativa: The Italian Experience
Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates – Italian Registry Hidradenitis Suppurativa project 2